214 results
8-K
EX-10.1
KANT
Kineta, Inc.
8 Jul 24
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences
6:30am
hereunder.
9.Compliance. Each Party is responsible for compliance with all applicable laws, rules, regulations, or ordinances which may relate to its
UPLOAD
t5hdnu
9 Nov 23
Letter from SEC
12:00am
8-K
EX-10.1
lo94d3j
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-4.3
j0w zemd5gm211bx1t6
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-4.2
si1nz
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-4.1
9yddkqcj
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
424B5
89f o1lnu
5 Oct 23
Prospectus supplement for primary offering
10:47am